Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor
Authors:
- Cheng Leng LeeCLCheng Leng Lee
- Su Ling YeoSYSu Ling Yeo
- Siew Pheng LimSLSiew Pheng Lim
- Mui Mui SimMSMui Mui Sim
- 1 January 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (2) , 91-94
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- NS3. A protease as a target for interfering with hepatitis C virus replicationDrug News & Perspectives, 2000
- Hepatitis C virus: an overview of current approaches and progressDrug Discovery Today, 1999
- Non‐peptide inhibitors of HCV serine proteinaseFEBS Letters, 1998
- Novel Hepatitis C virus Protease Inhibitors: 2,4,6-Trihydroxy,3-Nitro-Benzamide DerivativesAntiviral Chemistry and Chemotherapy, 1997
- Novel Hepatitis C Virus Protease Inhibitors: Thiazolidine DerivativesBiochemical and Biophysical Research Communications, 1997
- Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor PeptideCell, 1996
- The Crystal Structure of Hepatitis C Virus NS3 Proteinase Reveals a Trypsin-like Fold and a Structural Zinc Binding SiteCell, 1996
- Structure of Sch 68631: A new hepatitis C virus proteinase inhibitor from Streptomyces sp.Tetrahedron Letters, 1996
- Studies on Antidiabetic Agents. X. Synthesis and Biological Activities of Pioglitazone and Related Compounds.Chemical and Pharmaceutical Bulletin, 1991
- Preparations of 5-alkylmethylidene-3-carboxymethylrhodanine derivatives and their aldose reductase inhibitory activity.Chemical and Pharmaceutical Bulletin, 1990